Contracts › 75F40126C00027
75F40126C00027: Direct 8(A) Award, Stand-Alone, Labor-Hour (LH) Type Contract for Food and Drug Administration for Oncology Center of Excellence Benefits Risk Professional Services.
Awarded to Aneon Brillient, Llc by Food and Drug Administration (FDA).
$1.9Mobligated
$1.9Mpotential value
11 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126C00027 |
|---|---|
| Awardee | Aneon Brillient, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 Administrative Management and General Management Consulting Services |
| PSC | R699 Support- Administrative: Other |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 12 August 2026 to 11 August 2027 |
| Potential end | 11 August 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541611 contracts · All expiring contracts · USASpending record